PharmiWeb.com - Global Pharma News & Resources
12-Jan-2024 - 12-Jan-2024

Evidence strategy for Medical Technologies and Diagnostics

Join us for this live webinar on Friday 12th January at 2.00pm (GMT)/3.00pm (CET)/9.00am (EST) where our experts will be exploring evidence strategies for medical devices, diagnostics and digital health technologies.

Have you established the clinical and economic value of your medical device, diagnostic or digital technology? Do you have the evidence required to support your value proposition? Would a health technology assessment (HTA) route be appropriate for your product? What will payers, HTA agencies, and other key decision makers be looking for? And how should this information be presented?

In this webinar, our experts in HTAhealth economics, and commercialisation will explore the value of the META Tool assessment, providing insights on:

  • How to identify and communicate the value of your product for patients and the wider healthcare system
  • How to build a robust evidence package for successful launch and commercialisation
  • Key requirements for the National Institute for Health and Care Excellence (NICE) Medical Technologies Evaluation Programme (MTEP) or Diagnostics Assessment Programme (DAP)
  • Next steps to take your innovation to healthcare leaders across the NHS and beyond, with an impactful customer communication strategy

Register now at: https://register.gotowebinar.com/register/5936754095896862812

Learn more at: https://mtechaccess.co.uk/evidence-strategy-for-medical-technologies-and-diagnostics/

 

Meet our experts

Samantha Gillard (Director – HTA), Calum Jones (Senior Consultant – Health Economics), and Persefoni Ioannou (Consultant – HTA) recently passed the NICE META Tool assessment, enabling them to support our Medtech and Diagnostic clients through the META Tool process.

During this webinar, Samantha will lead the discussions with insights from Calum. Drawing on their experience of working on evidence generation for medical technologies and on MTEP and DAP submissions, they will explore how demonstration of clinical and economic evidence is gaining momentum. Hannah Palin (Associate Director – Market Access) will also join the discussions providing insights based on her practical experience of supporting launch and market expansion of medical devices, diagnostics, and digital health technologies.